000 01246 a2200361 4500
005 20250510212111.0
264 0 _c19790925
008 197909s 0 0 eng d
022 _a0065-2598
024 7 _a10.1007/978-1-4615-9101-6_104
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSeligmann, M
245 0 0 _aSumming-up--immunologic markers in human malignant lymphomas.
_h[electronic resource]
260 _bAdvances in experimental medicine and biology
_c1979
300 _a635-40 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntilymphocyte Serum
_xpharmacology
650 0 4 _aB-Lymphocytes
_ximmunology
650 0 4 _aCell Membrane
_ximmunology
650 0 4 _aCell Transformation, Neoplastic
650 0 4 _aCytoplasm
_ximmunology
650 0 4 _aFluorescent Antibody Technique
650 0 4 _aHaplorhini
650 0 4 _aHumans
650 0 4 _aLymphoma
_ximmunology
650 0 4 _aMice
650 0 4 _aPhenotype
650 0 4 _aReceptors, Antigen, B-Cell
650 0 4 _aT-Lymphocytes
_ximmunology
773 0 _tAdvances in experimental medicine and biology
_gvol. 114
_gp. 635-40
856 4 0 _uhttps://doi.org/10.1007/978-1-4615-9101-6_104
_zAvailable from publisher's website
999 _c109320
_d109320